Evaluación mediante las redes sociales de la información con la que cuentan los pacientes con EII

Evaluación mediante las redes sociales de la información con la que cuentan los pacientes con EII

RESUMEN Antecedentes y objetivos: para que las decisiones asistenciales sean compartidas por médico y paciente, la información adecuada del paciente es necesaria. Pretendemos conocer la valoración que los pacientes con enfermedad inflamatoria intestinal (EII) hacen de la información con la que cue...

Full description

Bibliographic Details
Main Authors:	Carmen Martín Fernández, Carlos Maroto Martín, Luis Fernández Salazar
Format:	Article
Language:	English
Published:	Aran Ediciones
Series:	Revista Espanola de Enfermedades Digestivas
Subjects:	Internet Crohn's disease Ulcerative colitis Information Social media Survey
Online Access:	http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082018000500002&lng=en&tlng=en

Similar Items

A population-based study on the incidence of inflammatory bowel disease in Oviedo (Northern Spain) Incidencia de la enfermedad inflamatoria intestinal (EII) en población general en el área de Oviedo
by: L. Rodrigo, et al.
Published: (2004-05-01)

A Case of Crohn’s Disease
by: Hosein Delshad, et al.
Published: (1997-09-01)

Pathology of Inflammatory Bowel Disease
by: Shiva Raj K.C.
Published: (2015-03-01)

Granulocitoaféresis en la enfermedad inflamatoria intestinal: Eficacia a 32 semanas con protocolo de inducción y sesiones de mantenimiento Granulocytapheresis in inflamatory bowel disease: Efficacy of an induction plus maintenance sessions protocol at 32 weeks
by: F. J. Fernández Pérez, et al.
Published: (2007-11-01)

The concerns of Spanish patients with inflammatory bowel disease as measured by the RFIPC questionnaire
by: E. del Berroa-de-la-Rosa, et al.

Vedolizumab in Inflammatory Bowel Disease: West versus East
by: Prasanta Debnath, et al.
Published: (2021-01-01)

Influence of the Treatment Used in Inflammatory Bowel Disease on the Protease Activities
by: Dudzińska E, et al.
Published: (2020-12-01)

The prevalence, characteristics, and determinants of anaemia in newly diagnosed patients with inflammatory bowel disease
by: Małgorzata Woźniak, et al.
Published: (2019-03-01)

Non Steroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease
by: Amir Klein, et al.
Published: (2010-04-01)

Profile of Inflammatory Bowel Disease in a Tertiary Care Centre of Eastern Nepal
by: Narendra Pandit, et al.
Published: (2018-11-01)

Histopathological changes in anatomical distribution of inflammatory bowel disease in children: a retrospective cohort study
by: Tsang Jessica, et al.
Published: (2012-10-01)

Two Cases of Pericarditis Associated with Inflammatory Bowel Disease
by: Bilge Tunc, et al.
Published: (2005-01-01)

Selective biologics for ulcerative colitis and Crohn's disease – clinical utility of vedolizumab
by: Petkau JM, et al.
Published: (2016-03-01)

The prevalence and clinical characteristics of anemia in Korean patients with inflammatory bowel disease
by: Dae Sung Lee, et al.
Published: (2016-01-01)

Imbalance of Controlled Death in Peripheral Blood Lymphocytes in Crohn’s Disease and Ulcerative Colitis
by: Ewa Dudzińska, et al.
Published: (2019-05-01)

Plasma Fibrinogen Levels in Inflammatory Bowel Disease Patients Compared to a Control Group
by: Mojgan Mokhtari, et al.
Published: (2012-02-01)

Leukocytapheresis in patients with inflammatory bowel diseases
by: Małgorzata Woźniak, et al.
Published: (2021-06-01)

Challenges in Pediatric Inflammatory Bowel Disease
by: Larisia Mihai, et al.
Published: (2019-08-01)

Thrombotic Complications in Inflammatory Bowel Disease
by: A. V. Borota, et al.
Published: (2019-05-01)

Sources of Bias in Common Diagnosis of Chronic Inflammatory Bowel Diseases
by: O. A. Svatkova, et al.
Published: (2020-12-01)

Experience with granulocytapheresis in Crohn's disease Experiencia con la granulocitoaféresis en la enfermedad de Crohn
by: F. Cuenca, et al.
Published: (2004-07-01)

Is safety infliximab during pregnancy in patients with inflammatory bowel disease? ¿El tratamiento con infliximab es seguro durante el embarazo en pacientes con enfermedad inflamatoria intestinal?
by: Federico Argüelles-Arias, et al.
Published: (2012-02-01)

Exploration of personality in the patients with the inflammatory bowel disease
by: Trikoš Lela, et al.
Published: (2019-01-01)

¿Cuándo es demasiado pronto y cuándo demasiado tarde para la cirugía en la enfermedad de Crohn? When is it too early or too late for surgery in Crohn's disease?
by: J. I. Fernández-Blanco Hernáiz, et al.
Published: (2008-01-01)

Análisis de polimorfismos genéticos del gen NOD2/CARD 15 y TLR4, asociados a enfermedades Inflamatorias Intestinales (EII) en pacientes chilenos
by: Peralta Bondi, Alexis Luis
Published: (2012)

Three‐year outcomes of childhood inflammatory bowel disease in New Zealand: A population‐based cohort study
by: Natalie G Martin, et al.
Published: (2020-08-01)

Role of Quality of Life as Endpoint for Inflammatory Bowel Disease Treatment
by: Cristina Calviño-Suárez, et al.
Published: (2021-07-01)

ТРУДНОСТИ ДИФФЕРЕНЦИАЛЬНОЙ ДИАГНОСТИКИ НЕСПЕЦИФИЧЕСКОГО ЯЗВЕННОГО КОЛИТА И БОЛЕЗНИ КРОНА В КЛИНИЧЕСКОЙ ПРАКТИКЕ. СОБСТВЕННОЕ НАБЛЮДЕНИЕ
by: Н. С. Хрулёва, et al.
Published: (2013-10-01)

Discriminant equation using mucosally expressed cytokines and transcription factor for making definite diagnosis of inflammatory bowel disease unclassified
by: Hiroaki Okuno, et al.
Published: (2021-02-01)

Interleukin 10 and interleukin 10 receptor in paediatric inflammatory bowel disease: from bench to bedside lesson
by: Paulina Krawiec, et al.
Published: (2021-03-01)

A pilot study of transrectal endoscopic ultrasound elastography in inflammatory bowel disease
by: Opacic Milorad, et al.
Published: (2011-10-01)

Effect of Vedolizumab on Anemia of Chronic Disease in Patients with Inflammatory Bowel Diseases
by: Patrizio Scarozza, et al.
Published: (2020-07-01)

IL23 Promotes Antimicrobial Pathways in Human Macrophages, Which Are Reduced With the IBD-Protective IL23R R381Q VariantSummary
by: Rui Sun, et al.
Published: (2020-01-01)

Up-to-date overview of imaging techniques in the diagnosis and management of inflammatory bowel diseases
by: Katarzyna B. Biernacka, et al.
Published: (2019-03-01)

Use of melatonin in combined treatment for inflammatory bowel diseases
by: Ol'ga Yur'evna Rakhimova, et al.
Published: (2010-12-01)

Management of Inflammatory Bowel Disease and Pregnancy using Prophylactic Low Dose Low Molecular Weight Heparin and Corticosteroids
by: Kemal Beksac, et al.
Published: (2017-11-01)

Cutaneous Manifestations in Inflammatory Bowel Diseases
by: Simona Roxana Georgescu, et al.
Published: (2015-10-01)

Diagnostic delay of pediatric inflammatory bowel disease in Saudi Arabia
by: Mohammad I El Mouzan, et al.
Published: (2019-01-01)

Cannabis for the Treatment of Inflammatory Bowel Disease: A True Medicine or a False Promise?
by: Timna Naftali, et al.
Published: (2020-01-01)

Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoring
by: Shu-Chen Wei, et al.
Published: (2018-10-01)